Akero Therapeutics (AKRO) EPS (2019 - 2025)
Akero Therapeutics (AKRO) EPS from Jun 30, 2019 to Sep 30, 2025. The TTM Akero Therapeutics (AKRO) EPS is -$6.27. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Akero Therapeutics (AKRO) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +17.27% |
| 3 Years TTM | +25.62% |
| 5 Years TTM | +23.95% |
| All Time TTM | +23.49% |
Annual EPS change of Akero Therapeutics (AKRO)
| Year | EPS | Change |
|---|---|---|
| 2025 | -$2.79 | -19.95% |
| 2024 | -$3.48 | +27.94% |
| 2023 | -$2.72 | +13.87% |
| 2022 | -$2.39 | -17.22% |
| 2021 | -$2.89 | +26.65% |
| 2020 | -$2.28 | +48.88% |
| 2019 | -$1.53 | N/A |
Comparison Akero Therapeutics (AKRO) five years EPS CAGR with competitors
Akero Therapeutics (AKRO) five years EPS CAGR is 23.96%.